2014-05-07 · Class II · Terminated
D-1287-2014 · AbbVie Inc
Leuprolide · Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Open attributed report →FDA enforcement report year
2014 FDA peptide enforcement reports
5 dated reports mapped only through exact reviewed application-number annotations.
2014-05-07 · Class II · Terminated
D-1288-2014 · AbbVie Inc
Leuprolide · Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Open attributed report →2014-05-07 · Class II · Terminated
D-1289-2014 · AbbVie Inc
Leuprolide · Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Open attributed report →2014-05-07 · Class II · Terminated
D-1290-2014 · AbbVie Inc
Leuprolide · Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Open attributed report →2014-05-07 · Class II · Terminated
D-1291-2014 · AbbVie Inc
Leuprolide · Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.
Open attributed report →